Jane Street Group, LLC Night Hawk Biosciences, Inc. Transaction History

Jane Street Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.26 - $0.51 $7,925 - $15,546	30,483 New	30,483 $13,000
Q4 2022 Feb 14, 2023	BUY	$0.77 - $1.62 $12,191 - $25,649	15,833 New	15,833 $12,000
Q2 2022 Aug 16, 2022	SELL	$1.65 - $3.13 $29,333 - $55,645	-17,778 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$2.1 - $3.54 $12,929 - $21,795	-6,157 Reduced 25.72%	17,778 $54,000
Q4 2021 Feb 15, 2022	BUY	$3.04 - $6.01 $72,762 - $143,849	23,935 New	23,935 $72,000

Ticker NHWK
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,661,500
Market Cap $4.11M
Description
NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.